Sign in

CIK 0000310158

  • Large accelerated filer

Merck & Co., Inc.

Sign in to watch
Ticker
MRK
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
Operating
EIN
221918501
Phone
+1 908-740-4000
Business address
126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
Former names
Merck & Co. Inc., SCHERING PLOUGH CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$8,611,875
in 1 filing

Net −$8,611,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. DeLuca Richard R. −$8.6M EVP&Pres, Merck Animal Heallth sold 34% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-11-01 FRAZIER KENNETH C Executive Chair Sale −202,319 $99.61 $20.2M 803,964.06
2022-11-01 FRAZIER KENNETH C Executive Chair Sale −96,981 $100.22 $9.7M 706,983.06
2022-11-01 FRAZIER KENNETH C Executive Chair Sale −700 $101.05 $71K 706,283.06
2022-11-01 FRAZIER KENNETH C Executive Chair Gift −1,710 704,573.06
2022-11-01 FRAZIER KENNETH C Executive Chair Gift −2,450 702,123.06
2022-11-01 FRAZIER KENNETH C Executive Chair Gift −1,470 700,653.06
2022-11-01 FRAZIER KENNETH C Executive Chair Exercise or conversion · Stock Option (Right to Buy) −300,000 165,828
2022-10-31 FRAZIER KENNETH C Executive Chair Exercise or conversion +300,000 1,006,283.06
2022-10-31 FRAZIER KENNETH C Executive Chair Sale −70,698 $99.82 $7.1M 935,585.06
2022-10-31 FRAZIER KENNETH C Executive Chair Sale −229,302 $101.03 $23.2M 706,283.06
2022-10-31 FRAZIER KENNETH C Executive Chair Exercise or conversion · Stock Option (Right to Buy) −300,000 465,828
2022-10-28 FRAZIER KENNETH C Executive Chair Exercise or conversion +567,084 1,273,367.06
2022-10-28 FRAZIER KENNETH C Executive Chair Sale −75,489 $99.15 $7.5M 1,197,878.06
2022-10-28 FRAZIER KENNETH C Executive Chair Sale −313,232 $100.25 $31.4M 884,646.06
2022-10-28 FRAZIER KENNETH C Executive Chair Sale −178,363 $100.80 $18.0M 706,283.06
2022-10-28 FRAZIER KENNETH C Executive Chair Exercise or conversion · Stock Option (Right to Buy) −567,084 0
2022-08-03 FRAZIER KENNETH C Executive Chair Grant or award · Restricted Stock Unit +28,532 28,532
2022-05-03 FRAZIER KENNETH C Executive Chair Grant or award · Restricted Stock Unit +28,703 28,703
2022-02-24 FRAZIER KENNETH C Executive Chair Grant or award +119,488 $73.51 $8.8M 706,283.06
2021-11-09 FRAZIER KENNETH C Executive Chair Exercise or conversion +663,881 1,250,676.06

Page 2 of 3 · 43 trades